Viatris - 37 Year Stock Price History | VTRS

Historical daily share price chart and data for Viatris since 1987 adjusted for splits and dividends. The latest closing stock price for Viatris as of November 05, 2024 is 11.61.
  • The all-time high Viatris stock closing price was 72.11 on April 24, 2015.
  • The Viatris 52-week high stock price is 13.62, which is 17.3% above the current share price.
  • The Viatris 52-week low stock price is 8.95, which is 22.9% below the current share price.
  • The average Viatris stock price for the last 52 weeks is 11.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Viatris Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 11.5413 11.3900 13.5300 10.0500 11.6100 7.20%
2023 10.1562 11.3800 12.2600 8.7700 10.8300 -2.70%
2022 10.9435 13.7850 14.9394 8.4800 11.1300 -15.20%
2021 13.9071 17.5777 17.5777 11.7284 13.1254 -26.13%
2020 16.0187 19.5782 21.6641 12.5718 17.7674 -6.77%
2019 21.1365 26.4709 30.4340 15.9281 19.0568 -26.64%
2018 35.9497 40.8725 45.1674 24.8497 25.9779 -35.24%
2017 35.7472 37.0801 42.9299 28.0922 40.1140 10.90%
2016 41.2413 50.5147 51.2826 32.3681 36.1700 -29.44%
2015 54.8370 53.4254 72.1124 37.1275 51.2637 -4.08%
2014 47.4273 40.3700 55.5775 40.0666 53.4443 29.88%
2013 32.1250 26.2623 42.1904 26.1106 41.1475 58.11%
2012 22.1121 21.0004 26.8312 19.5688 26.0253 27.91%
2011 20.3643 20.5358 23.9205 15.3213 20.3462 1.56%
2010 18.4182 17.7484 22.0433 15.9849 20.0333 14.65%
2009 13.5129 9.4999 18.0518 9.3483 17.4735 86.35%
2008 11.1024 13.1596 14.6007 5.4705 9.3767 -29.66%
2007 17.0068 18.8847 21.3954 12.5623 13.3303 -29.13%
2006 19.7697 18.6333 23.2171 17.8539 18.8093 1.15%
2005 16.9103 16.1817 20.0734 14.3077 18.5960 14.14%
2004 18.8162 23.0063 23.6474 13.4915 16.2923 -29.58%
2003 19.9336 14.3859 25.7599 14.3859 23.1346 63.53%
2002 12.7182 14.5951 14.5951 10.1535 14.1467 -6.43%
2001 11.7701 9.9014 15.2845 8.4216 15.1192 49.67%
2000 10.2044 9.7066 12.8648 6.7815 10.1019 0.68%
1999 9.6069 11.8425 12.3359 6.8693 10.0332 -19.31%
1998 10.8364 7.8736 13.8484 6.9669 12.4346 51.29%
1997 7.1001 6.4181 9.7934 4.4850 8.2190 27.06%
1996 6.8707 8.8212 8.8212 5.4328 6.4687 -28.60%
1995 7.8506 6.6072 9.3835 6.3493 9.0602 31.44%
1994 5.9806 6.1418 7.5504 4.0282 6.8931 7.24%
1993 7.1040 7.7145 9.2917 5.2062 6.4280 -19.01%
1992 5.5259 5.2029 7.9585 4.0118 7.9363 52.06%
1991 3.4509 2.4745 5.2192 2.1333 5.2192 103.14%
1990 2.5217 2.9357 3.0284 1.8124 2.5692 -14.29%
1989 1.5688 1.0889 3.0838 0.9367 2.9975 175.28%
1988 1.2373 1.0638 1.5952 0.9910 1.0889 8.55%
Sector Industry Market Cap Revenue
Medical Medical Services $13.858B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00